Document and Entity Information
Document and Entity Information | Jun. 21, 2023 |
Cover [Abstract] | |
Document Type | 8-K/A |
Document Period End Date | Jun. 21, 2023 |
Entity Registrant Name | MIND MEDICINE (MINDMED) INC. |
Entity Incorporation, State or Country Code | A1 |
Securities Act File Number | 001-40360 |
Entity Tax Identification Number | 98-1582438 |
Entity Address, Address Line One | One World Trade Center |
Entity Address, Address Line Two | Suite 8500 |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10007 |
City Area Code | 212 |
Local Phone Number | 220-6633 |
Title of 12(b) Security | Common Shares |
Trading Symbol | MNMD |
Security Exchange Name | NASDAQ |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Central Index Key | 0001813814 |
Amendment Flag | true |
Amendment Description | This Current Report on Form 8-K/A is being filed by Mind Medicine (MindMed) Inc. (the “Company”) as an amendment (the “Amendment”) to the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on June 27, 2023 (the “Original 8-K”) to announce the preliminary voting results of the Company’s 2023 Annual General Meeting of Shareholders held on June 21, 2023 (the “Annual Meeting”). This Amendment is being filed to disclose the final voting results as certified by First Coast Results, Inc. (the “Independent Inspector of Elections”), the independent inspector of elections for the Annual Meeting. |